Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.

Source:http://linkedlifedata.com/resource/pubmed/id/17638911

Cancer Res. 2007 Jul 15 67 14 6987-94

Download in:

View as

General Info

PMID
17638911